Dementia Death Rates in U.S. Older Adults Fluctuated From 2018 to 2022
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Nov. 13, 2024 -- Age-adjusted dementia deaths rates were stable between 2018 and 2019, then increased in 2020 and decreased slightly in 2022, according to a report published in the November Health E-Stats, a publication of the National Center for Health Statistics.
Ellen A. Kramarow, Ph.D., and Betzaida Tejada-Vera, from the National Center for Health Statistics in Hyattsville, Maryland, present age-adjusted death rates by sex, race and Hispanic origin, and place of death for adults aged 65 years and older with dementia as an underlying cause of death in 2018 to 2022.
The researchers found that the age-adjusted death rates for dementia were stable between 2018 and 2019. From 2019 to 2020, the rate increased by 10.2 percent, from 520.1 to 572.9 per 100,000 standard population, with death rates increasing by 7.1 and 11.8 percent for men and women, respectively. Between 2020 and 2022, there was a decline in death rates to 548.9, which was higher than the 2018 and 2019 rates. For women, dementia death rates declined each year from 2020 to 2022, while for men, rates declined from 2020 to 2021 and were then stable to 2022. Throughout the period, death rates were higher for women than men. During 2018 to 2022, dementia death rates were higher for White non-Hispanic than Black non-Hispanic and Hispanic adults.
Changes were observed in the place where dementia deaths occurred between 2018 and 2022, with a decrease in deaths occurring in nursing homes or long-term care facilities (53.6 to 44.6 percent) and an increase in deaths occurring at home (23.7 to 30.4 percent).
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-14 12:00
Read more
- American Society of Anesthesiologists, Oct. 18 to 22
- FDA Approves Revuforj (revumenib) for the Treatment of Adult and Pediatric Patients with Relapsed or Refractory Acute Leukemia with a KMT2A Translocation
- AbbVie Provides Update on Phase 2 Results for Emraclidine in Schizophrenia
- FDA Grants Accelerated Approval to Ziihera (zanidatamab-hrii) for the Treatment of HER2-Positive Biliary Tract Cancer
- FDA Proposes Ban on a 'Useless' Decongestant, Phenylephrine
- Flu Vaccine Coverage 80.7 Percent for Health Workers in Acute Care Hospitals
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions